Back

Characterization of novel cytoplasmic roles for the N-terminal methyltransferase NRMT1

Tooley, J. G.; Zhou, G.; Obeidat, S.; Arbel, A.; Jones, C.; Tedeschi, F.; Schaner Tooley, C.

2026-01-18 biochemistry
10.64898/2026.01.17.700099 bioRxiv
Show abstract

N-terminal methylation of proteins by the trimethylase NRMT1 plays important roles in oncogenesis, development, and aging. As N-terminal methylation has frequently been shown to regulate protein-DNA interactions, and many NRMT1 substrates are transcription factors or regulators of chromatin structure, previous research has focused on how transcriptional regulation by NRMT1 affects cell growth and differentiation. However, we have recently identified a new, cytoplasmic role for NRMT1, inhibiting the eukaryotic elongation factor 1 alpha (eEF1A) methyltransferase METTL13, which indicates NRMT1 could also be acting as a translational regulator. Here we further explore NRMT1 cytoplasmic functions and show that, unlike previously thought, NRMT1 can methylate substrates in the cytoplasm. We also show that while many of these substrates remain bound to NRMT1, it can also interact with a number of non-target ribosomal proteins and proteins associated with the endoplasmic reticulum (ER). To confirm NRMT1 interaction with the ribosome, we performed polysome profiling, which showed a portion of NRMT1 co-migrates with the 40S and 60S subunits but not with actively translating polysomes, indicating NRMT1 may play an early role in translation. To see if NRMT1 was affecting target mRNA selection of ribosomes, we also performed ribosome-sequencing experiments in proliferating and differentiating C2C12 mouse myoblasts. These results show a striking upregulation of translation of soluble proteins with NRMT1 loss and corresponding decrease in translation of transmembrane and signal sequence-containing proteins. We now propose a model where NRMT1 regulates the translation of transmembrane and secreted proteins by facilitating interactions between the ribosome and the ER.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nucleic Acids Research
1128 papers in training set
Top 1%
11.9%
2
eLife
5422 papers in training set
Top 7%
9.7%
3
Journal of Biological Chemistry
641 papers in training set
Top 0.1%
6.9%
4
Cell Reports
1338 papers in training set
Top 6%
6.9%
5
Nature Communications
4913 papers in training set
Top 31%
6.1%
6
iScience
1063 papers in training set
Top 3%
4.2%
7
Aging Cell
144 papers in training set
Top 1%
3.5%
8
PLOS Genetics
756 papers in training set
Top 5%
3.5%
50% of probability mass above
9
Biochemistry
130 papers in training set
Top 0.4%
3.0%
10
Life Science Alliance
263 papers in training set
Top 0.1%
3.0%
11
Scientific Reports
3102 papers in training set
Top 42%
3.0%
12
Open Biology
95 papers in training set
Top 0.3%
2.5%
13
Molecular Cell
308 papers in training set
Top 6%
1.8%
14
PLOS ONE
4510 papers in training set
Top 51%
1.8%
15
Cells
232 papers in training set
Top 3%
1.6%
16
Journal of Cell Biology
333 papers in training set
Top 2%
1.6%
17
ACS Chemical Biology
150 papers in training set
Top 1%
1.6%
18
Cell Chemical Biology
81 papers in training set
Top 2%
1.6%
19
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.6%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.4%
21
Molecular and Cellular Biology
40 papers in training set
Top 0.2%
1.4%
22
Journal of Molecular Biology
217 papers in training set
Top 2%
1.2%
23
PLOS Biology
408 papers in training set
Top 14%
1.2%
24
The EMBO Journal
267 papers in training set
Top 3%
1.2%
25
Journal of Proteome Research
215 papers in training set
Top 2%
0.9%
26
Epigenetics & Chromatin
42 papers in training set
Top 0.3%
0.8%
27
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.8%
0.7%
28
Journal of Cell Science
353 papers in training set
Top 3%
0.7%
29
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
14 papers in training set
Top 0.2%
0.7%
30
RNA
169 papers in training set
Top 0.5%
0.7%